Published in Ann N Y Acad Sci on January 01, 1988
Viral burden and HIV disease. Nature (1993) 3.18
In vitro anti-human immunodeficiency virus activities of tumor necrosis factor-alpha and interferon-gamma. J Immunol (1988) 2.21
Loss of CD45R (Lp220) represents a post-thymic T cell differentiation event. J Immunol (1988) 2.20
A requirement for antigen-specific helper T cells in the generation of cytotoxic T cells from thymocyte precursors. J Exp Med (1977) 2.18
Human immunodeficiency virus type 1-specific cytotoxic T lymphocyte activity is inversely correlated with HIV type 1 viral load in HIV type 1-infected long-term survivors. AIDS Res Hum Retroviruses (1999) 1.66
Dissociation of immunologic and virologic responses to highly active antiretroviral therapy. J Acquir Immune Defic Syndr (2000) 1.49
Clonal analysis of the peripheral T cell compartment of the SCID-hu mouse. J Immunol (1991) 1.26
Transient translocation of the B cell receptor and Src homology 2 domain-containing inositol phosphatase to lipid rafts: evidence toward a role in calcium regulation. J Immunol (2000) 1.24
Definition of the thymic generative lineage by selective expression of high molecular weight isoforms of CD45 (T200). Eur J Immunol (1989) 1.21
The effects of human immunodeficiency virus recombinant envelope glycoprotein on immune cell functions in vitro. Cell Immunol (1987) 1.17
Identification of a cytoplasmic region of CD20 required for its redistribution to a detergent-insoluble membrane compartment. J Immunol (1998) 1.11
Aberrant O-GlcNAcylation characterizes chronic lymphocytic leukemia. Leukemia (2010) 1.11
Monoclonal circulating B cells in multiple myeloma. A continuously differentiating, possibly invasive, population as defined by expression of CD45 isoforms and adhesion molecules. Hematol Oncol Clin North Am (1992) 1.10
Differential effects of filipin and methyl-beta-cyclodextrin on B cell receptor signaling. Biochem Biophys Res Commun (2001) 1.09
Relation of circulating levels of human immunodeficiency virus (HIV) antigen, antibody to p24, and HIV-containing immune complexes in HIV-infected patients. J Infect Dis (1988) 0.95
Regulation of CD3-induced phospholipase C-gamma 1 (PLC gamma 1) tyrosine phosphorylation by CD4 and CD45 receptors. Immunology (1992) 0.95
CD3-zeta surface expression is required for CD4-p56lck-mediated upregulation of T cell antigen receptor-CD3 signaling in T cells. J Biol Chem (1992) 0.94
Circulating monoclonal B cells expressing P glycoprotein may be a reservoir of multidrug-resistant disease in multiple myeloma. Blood (1994) 0.90
Abnormalities in lymphocyte profile and specificity repertoire of patients with Waldenstrom's macroglobulinemia, multiple myeloma, and IgM monoclonal gammopathy of undetermined significance. Am J Hematol (1989) 0.88
Regulated expression of a receptor for hyaluronan-mediated motility on human thymocytes and T cells. J Immunol (1993) 0.88
RHAMM, a receptor for hyaluronan-mediated motility, on normal human lymphocytes, thymocytes and malignant B cells: a mediator in B cell malignancy? Leuk Lymphoma (1994) 0.88
CD4, CD8 and the role of CD45 in T-cell activation. Curr Opin Immunol (1993) 0.86
A cholesterol-dependent CD20 epitope detected by the FMC7 antibody. Leukemia (2003) 0.84
A requirement for physical linkage between determinants recognized by helper molecules and cytotoxic T cell precursors in the induction of cytotoxic T cell responses. J Immunol (1986) 0.84
Abnormal clonogenic potential of T cells from multiple myeloma patients. Blood (1985) 0.81
HIV results in the frame. Paradox remains. Nature (1995) 0.81
Selective expression of CD45 isoforms and of maturation antigens during human thymocyte differentiation: observations and hypothesis. Immunol Lett (1989) 0.81
The association between CD20 and Src-family Tyrosine kinases requires an additional factor. Mol Immunol (1998) 0.80
Genetic and immunological host factors associated with susceptibility to HIV-1 infection. AIDS (1998) 0.80
Activation and tyrosine phosphorylation of protein kinase C delta in response to B cell antigen receptor stimulation. Mol Immunol (2000) 0.79
AIDS as immune system activation. Key questions that remain. Adv Exp Med Biol (1995) 0.79
Adhesive interactions in thymic development: does selective expression of CD45 isoforms promote stage-specific microclustering in the assembly of functional adhesive complexes on differentiating T lineage lymphocytes? Immunol Cell Biol (1993) 0.78
Comparative analysis of immunodeficiency in patients with monoclonal gammopathy of undetermined significance and patients with untreated multiple myeloma. Scand J Immunol (1989) 0.77
CD45 isoform transitions on multinegative human thymocytes differentiating in vitro mimic patterns predicted for selective events in vivo. Immunol Cell Biol (1993) 0.77
Induction of cytotoxic lymphocyte responses by antigen-specific helper factors. J Immunol (1984) 0.77
Intrinsic expression of the multidrug transporter, P-glycoprotein 170, in multiple myeloma: implications for treatment. Leuk Lymphoma (1995) 0.77
Analysis of peripheral blood lymphocyte populations and immune function from children exposed to cyclosporine or to azathioprine in utero. Transplantation (1994) 0.76
Deficiency in T cell responses of human fetal lymph node cells: a lack of accessory cells. Immunol Cell Biol (1995) 0.75
Limitations of plasma human immunodeficiency virus RNA testing. Clin Infect Dis (2000) 0.75
Immunotherapy for HIV. Lancet (1997) 0.75
Disproportionate utilization of plateletapheresis donors. Transfusion (1986) 0.75
Resistance and susceptibility to cyclosporin A as CD3-4-8- human thymocytes differentiate in vitro. Scand J Immunol (1994) 0.75
White cell related red cell antibodies. Transfusion (1983) 0.75
Apoptosis among CD45RA-/low CD3+ progeny accompanies differentiation of human multinegative thymocytes. Scand J Immunol (1995) 0.75
Comparative functional analysis of helper T lymphocyte responses to soluble and particulate antigens. J Immunol (1987) 0.75
HLA antibody screening. Transfusion (1984) 0.75
Multidrug resistance of a continuously differentiating monoclonal B lineage in the blood and bone marrow of patients with multiple myeloma. Curr Top Microbiol Immunol (1992) 0.75
Antigen-specific helper factor reacts with antibody to the T-cell receptor. J Immunogenet (1988) 0.75
Functional activity of soluble antigen-specific helper T cell molecules. Requirement for separable entities for the induction of cytotoxic T cell and B cell responses. Transplantation (1986) 0.75
Immunological characteristics of the putative CD4-binding site of the HIV-1 envelope protein. Pathobiology (1992) 0.75